Psychedelics as potential mental health treatment are explored by Trump administration
2025-06-07 09:00:12
The Trump administration has expressed interest in exploring a drug for its potential in the treatment of PTSD Mental health issuesMany officials participated.
“The administration shares the goal of ensuring that all Americans – especially the veterans of our nation – have safe and effective treatments for conditions such as PTSD, addiction and depression,” a SEC spokesman (HHS), which is run by SEC. Robert J. Kennedy Junior, in a statement presented to Fox News Digital.
“Kennedy minister is committed to applying strict science -based sciences on research efforts aimed at addressing this seriousness Health challenges“
Food and Drug Administration (FDA)
In recent years, researchers have been active in the capabilities of the drug, such as MDMA and Psilocybin (“Magic mushrooms) For the treatment of mental health disorders.
MDMA has not been approved for clinical use by the US Food and Drug Administration (FDA), but it can be studied in clinical environments.
Psilocybin is listed as materials in the first table under the Act of Control Materials, which means that “it has a high capacity of abuse, [is not] Currently acceptable for medical use in the treatment in the United States, and [has] There is no acceptable safety for use under medical supervision. “
However, the treatment with the help of legal cylospine in Oregon, Colorado and New Mexico.
The narcotic drugs “show a real promise”, according to Dr. Luke Infic, the general practitioner and deputy head of Medical for Lindus Health in London.
Clinical experiments have found such treatments safe and effective for patients who are fighting seriously Mental health Issues, according to a movie.
Studies show that common nutritional supplements and medications can cause liver damage
“Take silosipine, for example – it shows noticeable results of severe depression that did not respond to other drugs,” he told Fox News Digital. “MDMA shows similar breakthroughs to Treating post -trauma disorder“
Clinical trials also investigate how to help the drug in the end of life, addiction, Eating disordersHe added chronic pain and obsessive -compulsive disorder.
The researchers faced challenges in terms of organizational obstacles and appropriate imaginary drug controls.
“Given that these treatments can be transformed [the] He said, “The lives of people who suffer from the conditions in which nothing else succeeded effectively, is so important to complete this research. The goal is to bring safe and proven treatments to patients who need them more,” he said.
At the Prime Minister’s meeting on May 1, Department Old warriors affairs “We open the possibility of drug treatment,” said Minister Doug Collins.
retired Army Sergeant Jonathan Lopeci recently told Fox News’ ALEXANDRIA HOFF that MDMA stopped post -shock disorder while participating in a clinical trial.
“[I] I took the first dose of MDMA. I took it only three times as part of the clinical experience, and I have not taken it since then, and I have not found the need to take it since then, because I have not been infected with a post -trauma.
Peter Kasperovich, a press secretary for ancient warriors, told Fox News Digital that the department safely explores all ways that enhance the health of the veterans.
“Initial results have produced positive results on treatments with the help of anesthetic to treat mental health conditions,” he said.
VA currently operates 11 Clinical experiments In different stages, with a total of about 800 veterans who are expected to participate.
“The goal of these experiments is to determine whether vehicles such as MDMA and Psilocybin can treat old warriors with post -traumatic disorder, treatment of treatment resistant, severe depression, and possibly other mental disorder Health conditionsCasperovich said.
The MDMA study, published in the January 2025 issue of the American Psychiatric Magazine, found that the material “unlike the classic drug”.
I noticed the study, “MDMA allows the individual to preserve the proper ego From the cognitive Cognitive clarity while still suffers from a changing awareness of awareness that facilitates emotional therapeutic breakthroughs in depth. “
Click here to register in our health newsletter
The researchers concluded that MDMA showed “improved levels of confidence, sympathy, self -sympathy and” tolerance window “to which traditional psychotherapy lacks.
“Time has now come to address the mental health crisis,” told Cybin CEO Cybin, Fox News Digital.
He said it was “comfortable” that administration officials appreciate the potential benefits to research alternative mental health treatments.
Cybin is currently in stage 3 of the CYB003 study, a type of Psilocybin granted to the treatment of penetration by FDA as an additional treatment for Severe depression disorder (MDD).
“In the completed Cybin study in the second stage of MDD, the results of the event in the long term showed that 71 % of the participants were in a remission of depression, and 100 % of the participants responded to treatment in 12 months only 16 mg of two doses of Cyb003,” Dracedale said.
Dr. Mark Segel, Professor of Clinical Medicine at NYU Langone Medical Center A great medical analyst at Fox News, in the past, was an interview with two of the country’s leading drug researchers – Dr. Rachel Yehuda, founder and director of the anesthetic psychotherapy and trauma research in Mount Sinai in New York, and Dr. Charles Marmar, director of the post -trauma research program at NYU Langone.
“They agree on the presence of treatment capabilities if they are studied very carefully under very strict medical instructions, but there is a huge aspect in terms of unorganized recreational uses,” Siegel told Fox News Digital at the time.
“Both doctors see the potential therapeutic value of drugology if managed by Medical experts“He added.
Ryan Moss, the chief science official in Vitaam Health, a natural anesthetic development company in the clinical stage in Canada, confirmed that it is important to manage a drug in a safe environment when treating mental health conditions.
For more health articles, visit www.foxnews.com/health
“The narcotic experiences can sometimes be anxious, hallucinogenic, and bone insanity,” Moss told Fox News Digital. “Some patients who use a traditional anesthetic reported their exposure Cardiovascular events During clinical trials. “
To alleviate these risks, participants in clinical trials recommended experimental, participants in comprehensive preparation and monitoring by professionals trained during the sessions.
Melissa Rudi and Angelika Stapel, both of them from Fox News Digitter, contributed to the reports.
[og_img]
Post Comment